trial

How Can Rehospitalisations of Patients With Schizophrenia be Avoided? A Comparison Between Different Compliance Programs

NCTId NCT00514423
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 896 (estimated)
Sponsored by Technical University of Munich
Primary completion 2011-12
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
896 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
None
Start
2006-09
Primary completion
2011-12
Eligibility
ALL · 18 Years · 67 Years

Interventions & indications

Drugs
Psychoeducation by professonalsPsychoeducation by peer-moderatorsVideo-education

Sponsors

Technical University of MunichLead Sponsor

Investigators

1
Werner Kissling, MDPrincipal Investigator

Sites

1 total
München, Germany

Facts & assertions

4 sourced
Enrollment
896
Phase
NA
Primary Completion Date
2011-12
Status
COMPLETED
relationships
The graph out of here
drug
Psychoeducation by professonals
drug
Psychoeducation by peer-moderators
drug
Video-education
drug
lead_sponsor
Technical University of Munich
company
indication
Schizophrenia
indication
Schizoaffective Disorder
indication
Schizophrenia
indication
investigator
Werner Kissling, MD
person